The way decisions are made on prescribing medicines not deemed cost-effective will be simpler in future, according to the health secretary.
Health boards will decide whether or not to pay for a drug or treatment based on the "likely medical benefits" from September.
Previously, patients had to demonstrate they were "exceptional" cases.
It believes key decision-making criteria should be what the clinical benefits of medicines are and whether the treatment offers reasonable value for money.
Now we all know the benefits of T3 to those who need it, and we know the drug companies are charging whatever they like, so this may be a way of those of us who need T3 to argue for it? Of course for the Health Board paying the increased cost it is not value for money. How about tackling the obscene charges instead?